Slide 1: Earnings Conference Call Second Quarter 2022
ChromaDex Earnings Conference Call Second Quarter 2022 Rob Fried Chief Exe Kevin Farr Chief Financial Officer Nasdaq: CDXC | August 2022
Slide 2: Safe Harbor Statement
STATEMENT SAFE HARBOR
Slide 3: Q2 2022 & Recent Highlights
Q2 2022 & Recent Highlights + Total company and Tru Niagen® net sales down (5)% and (6)% YoY, respectivoly, with 13% growth in E-Comm Net sales remained relatively flat year over year excluding the initial shelf stocking sales to Wal-Mart in the second, ‘quarter of 2021. Watson's sales dectined $1.4
Slide 4: Management Team
Management Team
Slide 5: Financial Highlights
Financial Highlights
Slide 6: Q2 2022 Net Sales Mix
Q2 2022 Net Sales Mix Q2.2021 $17.7 MM erie Q2 2022 $16.7 MM ens oer 828 Moen mont grist + Tru Niagon® nat sales emai a 879 oft elas Yor 22022 and G2 2021" { Ningen-etated nt sats increased to 95% of nat sales n 22022 compare to 94% in G2 2021 ‘Lower mix of Watson’ tim year when sales were impacted
Slide 7: Q2 2022 Net Sales and 2022 Net Sales Growth Rates
Q2 2022 Net Sales 2 2022 Net Sales Growth Rates (Sinmilions) YoY % 200 % (8022021) (v5.01 2022) stas vasors tones Bs | wn sneer eeee [b> er (ears onm tot [om ore Tru Nlagen® bus nc (3)% sequentially driven by lower Watson's and Other BZB sales higher es So cromaten TRU NIAGEN
Slide 8: Year-to-Date 2022 Net Sales
Year-to-Date 2022 Net Sales ‘YTO 2022 Net Sales Yor % (Sinmilions) (s¥T0202) ——~ | moors sone os I >° | s794 ——t oe
Slide 9: 2020 - 2022 YTD Net Sales Summary
2020 — 2022 YTD Net Sales Summary Frauen een eT re a a es Secvemacec TRU NAGE
Slide 10: Q2 2022 vs Q1 2022 Key P&L Metrics
Q2 2022 vs Q1 2022 Key P&L Metrics @22022 12072 Notes ln tosana) "TuNagen anes down (7% ven by lowe Watsons 2 Oe ee $16,752 $17.259. a ean paaty ofvet by barr ECommerce ip *10%) Eerlstio! 10,092 10st Shane hcg woes homnesdasooscanne Setng ana Marketing e021 237 excances mn dt mada wr cbetbymvesirent
Slide 11: Q2 2022 vs Q2 2021 Key P&L Metrics
Q2 2022 vs Q2 2021 Key P&L Metrics “TuNogen® tunes own (6 covey ower Waters sas (Gone Covb trang pac rao Wo asses 2 tt sot secng 9 221) pray ety song gow RE enn (0135) ‘Donn 0k nary avn by ora rasa py can So ning rato oven bor se he rae \aiy wens empacing spa aaron conan ers ‘Up imo neeaesinvestents
Slide 12: Adjusted EBITDA Summary
Adjusted EBITDA Summary Reconciliation of Non-GAAP Financ Measures (intoosans) ton, ls sans ars azis earls mains wrens wens als mrs (am siamese Bepecatan moe mae] at] wtf a Ione agin a ee) |e) Ionatn cage fue at & 8 SF we] ema] AgundeBTOAncseplgaecese — |F_GORIS TSS ERTS OAS BOIS BOS ems aes aaa a o
Slide 13: Q2 2022 Operating Loss vs Q2 2021
Q2 2022 Operating Loss vs Q2 2021 Se cromabec RU NAGEN
Slide 14: Quarterly Balance Sheet Highlights
Quarterly Balance Sheet Highlights (in nowsens) ee ne me mars soventery M195 Hers tzrez rages 207s | RBH 5307 18759 meninonstomigped roe less Rectonwe on 30 azay Denby mil canoe sae ee aes | same a ca ee ‘rman y change erent nd Inecred nbn | 4AiS GHD 7am8 sen 6301 | Gay 8126 cane Sant noun acres aer
Slide 15: Quarterly Cash Flow Highlights
Quarterly Cash Flow Highlights Faas Fy2019 FY2020 anti 60071 oat ava Fv2021 ania enon lester Pas kc [casn From (Usedton Operations | 0439)" (E08) | 405) 7.095) om aes. | BRIE) | ) GRD) See Co Ietincreae/(Decrease)incash | $B) $AIHB) | $2790 (591) sinery suse | Sits S727 sas2) | f Investments to grow
Slide 16: 2022 Financial Outlook
2022 Financial Outlook Ee 2222 Fun Year 719 oxtook Key Daves Curt FY too) on sng pts own or + secon utiors and ST SAS ry 10H "et Zens ona Austaus Gots Teor 7 yoga ta ition, anaes Seay aie haw rane smty Miata ttre am & onion? pseeaay iter eens coe ‘Down approx $6307 en + Sula cen oa me. 2 roach this
Slide 17: Q2 2022 Financial Highlights - Recap
Q2 2022 Financial Highlights - Recap ‘otal not sales of $16.7 milion in G2 2022((5)% YoY, (3)% versus Qt 2022) Continued progress building the Tru Niagen® brand Tru Niagen® net sales of S14 5 millon in 02 2022 (6)% YOY, (3) vs Qt 2022) Consistently strong gross margin of 60% ((100)bps vs Q1 2022 and
Slide 18: The Science
The Science
Slide 19: Science Continues to Expand
Science Continues to Expand ‘Two new human trials on nicotinamide riboside registered since prior update: ‘Oxegon Health and Science University (June 2022) “The purpose of the study isto determine if an oral ketone beverage (consisting of NR and othr ingredients is safe and well tolerated during mod
Slide 20: Scientific Advisory Board
Scientific Advisory Board
Slide 21: Basic Physiological Functions are NAD+ Dependent
Basic Physiological Functions are NAD+ Dependent
Slide 22: Contact Info
Contact Info Brianna Gerber ‘SVP, Finance /Invarim Chief Financial Officer T: +1.949.419.0288 ext. 127 BidannaS@ehromader.com woww.chron Where to buy TRU NIAGEN® tnuniagen.com amazon.com Walmart.com and select Walmart Fy